Annual FCF
$1.13 B
+$224.46 M+24.75%
31 December 2022
Summary:
Horizon Therapeutics Public Limited annual free cash flow is currently $1.13 billion, with the most recent change of +$224.46 million (+24.75%) on 31 December 2022. During the last 3 years, it has risen by +$775.73 million (+218.00%).HZNP Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
$143.00 M
+$95.81 M+203.00%
30 June 2023
Summary:
Horizon Therapeutics Public Limited quarterly free cash flow is currently $143.00 million, with the most recent change of +$95.81 million (+203.00%) on 30 June 2023.HZNP Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
$906.13 M
-$96.04 M-9.58%
30 June 2023
Summary:
Horizon Therapeutics Public Limited TTM free cash flow is currently $906.13 million, with the most recent change of -$96.04 million (-9.58%) on 30 June 2023.HZNP TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HZNP Free Cash Flow Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | - | - |
3 y3 years | +218.0% | -57.6% | +23.5% |
5 y5 years | +536.5% | +72.2% | +175.9% |
HZNP Free Cash Flow High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | ||||||
5 y | 5 years | ||||||
alltime | all time | at high | -72.3% | -28.6% |
Horizon Therapeutics Public Limited Free Cash Flow History
Date | Annual | Quarterly | TTM |
---|---|---|---|
June 2023 | - | $143.00 M(+203.0%) | $906.13 M(-9.6%) |
Mar 2023 | - | $47.20 M(-87.6%) | $1.00 B(-11.4%) |
Dec 2022 | $1.13 B(+24.7%) | $379.28 M(+12.7%) | $1.13 B(-10.8%) |
Sept 2022 | - | $336.65 M(+40.8%) | $1.27 B(-0.0%) |
June 2022 | - | $239.04 M(+35.4%) | $1.27 B(+14.8%) |
Mar 2022 | - | $176.59 M(-65.8%) | $1.11 B(+21.9%) |
Dec 2021 | $907.10 M(+154.9%) | $516.58 M(+53.2%) | $907.10 M(+23.6%) |
Sept 2021 | - | $337.10 M(+346.6%) | $733.88 M(+49.1%) |
June 2021 | - | $75.48 M(-442.1%) | $492.22 M(-4.5%) |
Mar 2021 | - | -$22.06 M(-106.4%) | $515.37 M(+44.8%) |
Dec 2020 | $355.84 M(-12.9%) | $343.36 M(+259.8%) | $355.84 M(+80.3%) |
Sept 2020 | - | $95.43 M(-3.2%) | $197.32 M(+6.7%) |
June 2020 | - | $98.64 M(-154.3%) | $184.94 M(+7.2%) |
Mar 2020 | - | -$181.60 M(-198.2%) | $172.56 M(-57.8%) |
Dec 2019 | $408.48 M(+129.8%) | $184.85 M(+122.6%) | $408.48 M(+24.4%) |
Sept 2019 | - | $83.05 M(-3.7%) | $328.44 M(-0.5%) |
June 2019 | - | $86.26 M(+58.8%) | $330.14 M(+8.0%) |
Mar 2019 | - | $54.32 M(-48.2%) | $305.57 M(+71.9%) |
Dec 2018 | $177.77 M(-36.5%) | $104.82 M(+23.7%) | $177.77 M(-17.7%) |
Sept 2018 | - | $84.74 M(+37.4%) | $215.91 M(+9.0%) |
June 2018 | - | $61.69 M(-184.0%) | $198.11 M(+8.2%) |
Mar 2018 | - | -$73.48 M(-151.4%) | $183.15 M(-34.6%) |
Dec 2017 | $280.00 M(-20.8%) | $142.95 M(+113.5%) | $280.00 M(+1.8%) |
Sept 2017 | - | $66.95 M(+43.3%) | $275.13 M(-17.9%) |
June 2017 | - | $46.72 M(+99.8%) | $335.13 M(+1.4%) |
Mar 2017 | - | $23.38 M(-83.1%) | $330.46 M(-6.6%) |
Dec 2016 | $353.73 M | $138.08 M(+8.8%) | $353.73 M(+1.7%) |
Sept 2016 | - | $126.95 M(+201.9%) | $347.95 M(+13.3%) |
June 2016 | - | $42.05 M(-9.9%) | $307.15 M(+0.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2016 | - | $46.66 M(-64.7%) | $305.98 M(+63.6%) |
Dec 2015 | $187.01 M(+677.6%) | $132.30 M(+53.6%) | $187.01 M(+196.2%) |
Sept 2015 | - | $86.15 M(+110.7%) | $63.13 M(-382.4%) |
June 2015 | - | $40.88 M(-156.5%) | -$22.35 M(-52.5%) |
Mar 2015 | - | -$72.32 M(-959.3%) | -$47.02 M(-295.5%) |
Dec 2014 | $24.05 M(-143.3%) | $8.42 M(+1163.7%) | $24.05 M(+516.6%) |
Sept 2014 | - | $666.00 K(-95.9%) | $3.90 M(-160.0%) |
June 2014 | - | $16.22 M(-1396.4%) | -$6.50 M(-80.7%) |
Mar 2014 | - | -$1.25 M(-89.3%) | -$33.74 M(-39.2%) |
Dec 2013 | -$55.48 M(-28.8%) | -$11.73 M(+20.5%) | -$55.48 M(-9.4%) |
Sept 2013 | - | -$9.74 M(-11.6%) | -$61.24 M(-17.6%) |
June 2013 | - | -$11.02 M(-52.1%) | -$74.30 M(-7.2%) |
Mar 2013 | - | -$22.99 M(+31.5%) | -$80.05 M(+2.7%) |
Dec 2012 | -$77.98 M(+80.7%) | -$17.49 M(-23.3%) | -$77.98 M(+2.3%) |
Sept 2012 | - | -$22.80 M(+36.0%) | -$76.24 M(+8.7%) |
June 2012 | - | -$16.77 M(-19.9%) | -$70.15 M(+21.9%) |
Mar 2012 | - | -$20.92 M(+32.8%) | -$57.53 M(+33.3%) |
Dec 2011 | -$43.14 M(+12.8%) | -$15.76 M(-5.7%) | -$43.14 M(+21.0%) |
Sept 2011 | - | -$16.71 M(+303.2%) | -$35.67 M(+16.9%) |
June 2011 | - | -$4.14 M(-36.6%) | -$30.50 M(-23.8%) |
Mar 2011 | - | -$6.54 M(-21.0%) | -$40.01 M(+4.6%) |
Dec 2010 | -$38.25 M(+101.2%) | -$8.28 M(-28.2%) | -$38.25 M(+10.2%) |
Sept 2010 | - | -$11.54 M(-15.5%) | -$34.69 M(+26.1%) |
June 2010 | - | -$13.65 M(+185.9%) | -$27.52 M(+48.8%) |
Mar 2010 | - | -$4.78 M(+1.1%) | -$18.49 M(-2.7%) |
Dec 2009 | -$19.01 M(-23.2%) | -$4.72 M(+8.3%) | -$19.01 M(+33.1%) |
Sept 2009 | - | -$4.36 M(-5.7%) | -$14.29 M(+43.9%) |
June 2009 | - | -$4.63 M(-12.6%) | -$9.92 M(+87.4%) |
Mar 2009 | - | -$5.30 M | -$5.30 M |
Dec 2008 | -$24.76 M | - | - |
FAQ
- What is Horizon Therapeutics Public Limited annual free cash flow?
- What is the all time high annual FCF for Horizon Therapeutics Public Limited?
- What is Horizon Therapeutics Public Limited quarterly free cash flow?
- What is the all time high quarterly FCF for Horizon Therapeutics Public Limited?
- What is Horizon Therapeutics Public Limited TTM free cash flow?
- What is the all time high TTM FCF for Horizon Therapeutics Public Limited?
What is Horizon Therapeutics Public Limited annual free cash flow?
The current annual FCF of HZNP is $1.13 B
What is the all time high annual FCF for Horizon Therapeutics Public Limited?
Horizon Therapeutics Public Limited all-time high annual free cash flow is $1.13 B
What is Horizon Therapeutics Public Limited quarterly free cash flow?
The current quarterly FCF of HZNP is $143.00 M
What is the all time high quarterly FCF for Horizon Therapeutics Public Limited?
Horizon Therapeutics Public Limited all-time high quarterly free cash flow is $516.58 M
What is Horizon Therapeutics Public Limited TTM free cash flow?
The current TTM FCF of HZNP is $906.13 M
What is the all time high TTM FCF for Horizon Therapeutics Public Limited?
Horizon Therapeutics Public Limited all-time high TTM free cash flow is $1.27 B